83 FR 28001 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 116 (June 15, 2018)

Page Range		28001-28002
FR Document		2018-12839

Federal Register, Volume 83 Issue 116 (Friday, June 15, 2018)

[Federal Register Volume 83, Number 116 (Friday, June 15, 2018)]
[Notices]
[Pages 28001-28002]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-12839]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Neurodevelopment and Psychiatric Disorders.
    Date: June 27-28, 2018.
    Time: 8:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Samuel C. Edwards, Ph.D., Chief, Brain Disorders 
and Clinical Neuroscience, Center for Scientific Review, National 
Institutes of Health, 6701 Rockledge Drive, Room 5210, MSC 7846, 
Bethesda, MD 20892, (301) 435-1246, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Infectious Diseases and Microbiology AREA Review.
    Date: July 13, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Edgewater Hotel, 2411 Alaskan Way, Pier 67, Seattle, WA 
98121.
    Contact Person: Liangbiao Zheng, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3202, MSC 7808, Bethesda, MD 
20892, 301-996-5819, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Psychopathology, Aging, and Cognition.
    Date: July 13, 2018.
    Time: 1:30 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Maribeth Champoux, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3170, MSC 7848, Bethesda, MD 
20892, 301-594-3163, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Topics in Drug Resistance, Drug Discovery 
and Clinical and Field Research.
    Date: July 16-17, 2018.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Tera Bounds, DVM, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3214, MSC 7808, Bethesda, MD 
20892, 301-435-2306, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Topics in Bacterial Pathogenesis.
    Date: July 16, 2018.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Zoe Fisherman's Wharf, 425 North Point, San 
Francisco, CA 94133.
    Contact Person: Richard G. Kostriken, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD 
20892, 240-519-7808, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Gastrointestinal and Pancreatic 
Physiopathology.
    Date: July 16, 2018.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Martha Garcia, Ph.D., Scientific Reviewer 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 2186, MSC 7818, Bethesda, MD 
20892, 301-435-1243, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member

[[Page 28002]]

Conflict: Healthcare Delivery and Methodologies.
    Date: July 16, 2018.
    Time: 2:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Karin F. Helmers, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3166, MSC 7770, Bethesda, MD 
20892, 301-254-9975, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: June 8, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-12839 Filed 6-14-18; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 116 / Friday, June 15, 2018 / Notices 28001

Dated: June 8, 2018. Place: National Institutes of Health, 6701 Place: Edgewater Hotel, 2411 Alaskan Way,
Leslie Kux, Rockledge Drive, Bethesda, MD 20892 Pier 67, Seattle, WA 98121.
(Telephone Conference Call). Contact Person: Liangbiao Zheng, Ph.D.,
Associate Commissioner for Policy.
Contact Person: Peter B. Guthrie, Ph.D., Scientific Review Officer, Center for
[FR Doc. 2018–12894 Filed 6–14–18; 8:45 am] Scientific Review Officer, Center for Scientific Review, National Institutes of
BILLING CODE 4164–01–P Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3202,
Health, 6701 Rockledge Drive, Room 4142, MSC 7808, Bethesda, MD 20892, 301–996–
MSC 7850, Bethesda, MD 20892, (301) 435– 5819, zhengli@csr.nih.gov.
DEPARTMENT OF HEALTH AND 1239, guthriep@csr.nih.gov. Name of Committee: Center for Scientific
HUMAN SERVICES (Catalogue of Federal Domestic Assistance Review Special Emphasis Panel; Member
Program Nos. 93.306, Comparative Medicine; Conflict: Psychopathology, Aging, and
National Institutes of Health 93.333, Clinical Research, 93.306, 93.333, Cognition.
93.337, 93.393–93.396, 93.837–93.844, Date: July 13, 2018.
Center for Scientific Review; Notice of 93.846–93.878, 93.892, 93.893, National Time: 1:30 p.m. to 4:00 p.m.
Closed Meetings Institutes of Health, HHS) Agenda: To review and evaluate grant
applications.
Dated: June 11, 2018.
Pursuant to section 10(d) of the Place: National Institutes of Health, 6705
Sylvia L. Neal, Rockledge Drive, Bethesda, MD 20817
Federal Advisory Committee Act, as
Program Analyst, Office of Federal Advisory (Telephone Conference Call).
amended, notice is hereby given of the Committee Policy. Contact Person: Maribeth Champoux,
following meetings. Ph.D., Scientific Review Officer, Center for
[FR Doc. 2018–12836 Filed 6–14–18; 8:45 am]
The meetings will be closed to the Scientific Review, National Institutes of
BILLING CODE 4140–01–P
public in accordance with the Health, 6701 Rockledge Drive, Room 3170,
provisions set forth in sections MSC 7848, Bethesda, MD 20892, 301–594–
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 3163, champoum@csr.nih.gov.
DEPARTMENT OF HEALTH AND
as amended. The grant applications and Name of Committee: Center for Scientific
HUMAN SERVICES
the discussions could disclose Review Special Emphasis Panel; Member
confidential trade secrets or commercial Conflict: Topics in Drug Resistance, Drug
National Institutes of Health Discovery and Clinical and Field Research.
property such as patentable material, Date: July 16–17, 2018.
and personal information concerning Center for Scientific Review; Notice of Time: 8:00 a.m. to 6:00 p.m.
individuals associated with the grant Closed Meetings Agenda: To review and evaluate grant
applications, the disclosure of which Pursuant to section 10(d) of the applications.
would constitute a clearly unwarranted Federal Advisory Committee Act, as
Place: National Institutes of Health, 6701
invasion of personal privacy. Rockledge Drive, Bethesda, MD 20892
amended (5 U.S.C. App.), notice is (Virtual Meeting).
Name of Committee: Center for Scientific hereby given of the following meetings. Contact Person: Tera Bounds, DVM, Ph.D.,
Review Special Emphasis Panel; The meetings will be closed to the Scientific Review Officer, Center for
Fellowships: Musculoskeletal and Oral public in accordance with the Scientific Review, National Institutes of
Sciences, Imaging, Surgery and Informatics. provisions set forth in sections Health, 6701 Rockledge Drive, Room 3214,
Date: July 10–11, 2018. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., MSC 7808, Bethesda, MD 20892, 301–435–
Time: 8:00 a.m. to 5:00 p.m. 2306, boundst@csr.nih.gov.
Agenda: To review and evaluate grant
as amended. The grant applications and
the discussions could disclose Name of Committee: Center for Scientific
applications. Review Special Emphasis Panel; Topics in
Place: Residence Inn Bethesda, 7335 confidential trade secrets or commercial
Bacterial Pathogenesis.
Wisconsin Avenue, Bethesda, MD 20814. property such as patentable material,
Date: July 16, 2018.
Contact Person: Anshumali Chaudhari, and personal information concerning Time: 8:00 a.m. to 6:00 p.m.
Ph.D., Scientific Review Officer, Center for individuals associated with the grant Agenda: To review and evaluate grant
Scientific Review, National Institutes of applications, the disclosure of which applications.
Health, 6701 Rockledge Drive, Room 4124, would constitute a clearly unwarranted Place: Hotel Zoe Fisherman’s Wharf, 425
MSC 7802, Bethesda, MD 20892, (301) 435– invasion of personal privacy. North Point, San Francisco, CA 94133.
1210, chaudhaa@csr.nih.gov. Contact Person: Richard G. Kostriken,
Name of Committee: Center for Scientific
Name of Committee: Center for Scientific Ph.D., Scientific Review Officer, Center for
Review Special Emphasis Panel; Member
Review Special Emphasis Panel; Platforms to Scientific Review, National Institutes of
Conflict: Neurodevelopment and Psychiatric
Evaluate Adverse Biological Consequences of Health, 6701 Rockledge Drive, Room 3192,
Disorders.
Cell Genome Editing. MSC 7808, Bethesda, MD 20892, 240–519–
Date: June 27–28, 2018.
Date: July 10, 2018. Time: 8:00 a.m. to 8:00 p.m. 7808, kostrikr@csr.nih.gov.
Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant Name of Committee: Center for Scientific
Agenda: To review and evaluate grant applications. Review Special Emphasis Panel; Member
applications. Place: National Institutes of Health, 6701 Conflict: Gastrointestinal and Pancreatic
Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 Physiopathology.
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Date: July 16, 2018.
(Virtual Meeting). Contact Person: Samuel C. Edwards, Ph.D., Time: 1:00 p.m. to 4:00 p.m.
Contact Person: Methode Bacanamwo, Chief, Brain Disorders and Clinical Agenda: To review and evaluate grant
Ph.D., Scientific Review Officer, Center for Neuroscience, Center for Scientific Review, applications.
Scientific Review, National Institutes of National Institutes of Health, 6701 Rockledge Place: National Institutes of Health, 6701
Health, 6701 Rockledge Drive, Room 2200, Drive, Room 5210, MSC 7846, Bethesda, MD Rockledge Drive, Bethesda, MD 20892
Bethesda, MD 20892, 301–827–7088, 20892, (301) 435–1246, edwardss@ (Telephone Conference Call).
sradovich on DSK3GMQ082PROD with NOTICES

methode.bacanamwo@nih.gov. csr.nih.gov. Contact Person: Martha Garcia, Ph.D.,
Name of Committee: Center for Scientific Name of Committee: Center for Scientific Scientific Reviewer Officer, Center for
Review Special Emphasis Panel; Member Review Special Emphasis Panel; Infectious Scientific Review, National Institutes of
Conflict: Neuropharmacology. Diseases and Microbiology AREA Review. Health, 6701 Rockledge Drive, Room 2186,
Date:.July 11, 2018. Date: July 13, 2018. MSC 7818, Bethesda, MD 20892, 301–435–
Time: 1:00 p.m. to 5:00 p.m. Time: 8:00 a.m. to 5:00 p.m. 1243, garciamc@nih.gov.
Agenda: To review and evaluate grant Agenda: To review and evaluate grant Name of Committee: Center for Scientific
applications. applications. Review Special Emphasis Panel; Member

VerDate Sep<11>2014 17:11 Jun 14, 2018 Jkt 244001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\15JNN1.SGM 15JNN1

28002 Federal Register / Vol. 83, No. 116 / Friday, June 15, 2018 / Notices

Conflict: Healthcare Delivery and comments relating to the contemplated issued 03/15/2012, entitled ‘‘Functional
Methodologies. exclusive patent commercialization Epitopes of Streptococcus Pneumonia
Date: July 16, 2018. license should be directed to: Karen PSAA Antigen and Uses Thereof’’ (HHS
Time: 2:00 p.m. to 5:00 p.m.
Surabian, Licensing and Patenting Reference No. E–338–2013/0–AU–03);
Agenda: To review and evaluate grant
applications. Manager, Technology Transfer and European Patent Number 1931700,
Place: National Institutes of Health, 6701 Intellectual Property Office, National issued 07/17/2003, entitled ‘‘Functional
Rockledge Drive, Bethesda, MD 20892 Institute of Allergy and Infectious Epitopes of Streptococcus Pneumonia
(Telephone Conference Call). Diseases, 5601 Fishers Lane, Suite 6D, PSAA Antigen and Uses Thereof’’ (HHS
Contact Person: Karin F. Helmers, Ph.D., MSC9804, Rockville, MD 20852–9804, Reference No. E–338–2013/0–EP–04),
Scientific Review Officer, Center for phone number 301–496–2644, or and validated in: Germany, Spain,
Scientific Review, National Institutes of France, the United Kingdom, and
karen.surabian@nih.gov.
Health, 6701 Rockledge Drive, Room 3166,
SUPPLEMENTARY INFORMATION: The Ireland; Hong Kong Patent Number
MSC 7770, Bethesda, MD 20892, 301–254–
9975, helmersk@csr.nih.gov. following represents the intellectual 1115144, issued 02/14/2014, entitled
(Catalogue of Federal Domestic Assistance property to be licensed under the ‘‘Functional Epitopes of Streptococcus
Program Nos. 93.306, Comparative Medicine; prospective agreement: United States Pneumonia PSAA Antigen and Uses
93.333, Clinical Research, 93.306, 93.333, Provisional Patent Application Number Thereof’’ (HHS Reference No. E–338–
93.337, 93.393–93.396, 93.837–93.844, 61/085,208, filed 07/31/2008, entitled 2013/0–HK–05); United States Patent
93.846–93.878, 93.892, 93.893, National ‘‘Methods of Enhancing Number 7,919,104, issued 04/05/2011,
Institutes of Health, HHS) entitled ‘‘Functional Epitopes of
Opsonophagocytosis in Response to a
Dated: June 8, 2018. Pathogen’’ (HHS Reference No. E–329– Streptococcus Pneumonia PSAA
Sylvia L. Neal, 2013/0–US–01); PCT Patent Application Antigen and Uses Thereof’’ (HHS
Program Analyst, Office of Federal Advisory Number PCT/US2009/052384, filed 07/ Reference No. E–338–2013/0–US–06);
Committee Policy. 31/2009, entitled ‘‘Methods of Canada Patent Application Number
[FR Doc. 2018–12839 Filed 6–14–18; 8:45 am] Enhancing Opsonophagocytosis in 2,631,556, filed 09/15/2014, entitled
Response to a Pathogen’’ (HHS ‘‘Functional Epitopes of Streptococcus
BILLING CODE 4140–01–P
Pneumonia PSAA Antigen and Uses
Reference No. E–329–2013/0–PCT–02);
Thereof’’ (HHS Reference No. E–338–
China Patent Number 200980137625.X,
DEPARTMENT OF HEALTH AND 2013/0–CA–07); Australia Patent
issued 11/26/2014, entitled ‘‘Methods of
HUMAN SERVICES Number 2012201107, issued 06/06/
Enhancing Opsonophagocytosis in
2013, entitled ‘‘Functional Epitopes of
Response to a Pathogen’’ (HHS
National Institutes of Health Streptococcus Pneumonia PSAA
Reference No. E–329–2013/0–CN–03);
Antigen and Uses Thereof’’ (HHS
European Patent Number 2323684,
Prospective Grant of Exclusive Patent Reference No. E–338–2013/0–AU–08);
issued 05/21/2014, entitled ‘‘Use of a
Commercialization License: Hong Kong Patent Number HK1163113,
Pneumococcal P4 Peptide for Enhancing
Streptococcus Pneumonia PSAA issued 06/05/2015, entitled ‘‘Functional
Opsonophagocytosis in Response to a Epitopes of Streptococcus Pneumonia
Peptide for Treatment of Sepsis and
Pathogen’’ (HHS Reference No. E–329– PSAA Antigen and Uses Thereof’’ (HHS
Infection
2013/0–EP–04), and validated in Reference No. E–338–2013/0–HK–09);
AGENCY: National Institutes of Health, Germany, Spain, France, the United European Patent Number 2371843,
Centers for Disease Control and Kingdom, and Ireland; Hong Kong issued 09/17/2014, entitled ‘‘Functional
Prevention, Department of Health and Patent Number 1160391, issued 07/31/ Epitopes of Streptococcus Pneumonia
Human Services. 2015, entitled ‘‘Methods of Enhancing PSAA Antigen and Uses Thereof’’ (HHS
ACTION: Notice. Opsonophagocytosis in Response to a Reference No. E–338–2013/0–EP–10),
Pathogen’’ (HHS Reference No. E–329– and validated in: Germany, France, and
SUMMARY: The National Institute of 2013/0–HK–05); United States Patent
Allergy and Infectious Diseases, an the United Kingdom.
Number 8,431,134, issued 04/30/2013, All rights in these inventions have
institute of the National Institutes of entitled ‘‘Use of a Pneumococcal P4 been assigned to the Government of the
Health, Department of Health and Peptide for Enhancing United States of America.
Human Services, on behalf of the Opsonophagocytosis in Response to a The prospective exclusive patent
Centers for Disease Control and Pathogen’’ (HHS Reference No. E–329– commercialization license territory may
Prevention, Department of Health and 2013/0–US–06); United States Patent be worldwide and the field of use may
Human Services, is contemplating the Number 9,101,582, issued 08/11/2015, be limited to: ‘‘Development,
grant of an exclusive patent entitled ‘‘Use of a Pneumococcal P4 manufacture, and sale of a P4 peptide
commercialization license to The Peptide for Enhancing therapeutic for the treatment of
University of Liverpool, located in Opsonophagocytosis in Response to a infection and sepsis.’’
Liverpool, UK, to practice the Pathogen’’ (HHS Reference No. E–329– These inventions, developed within
inventions embodied in the patent 2013/0–US–07); United States the National Center for Immunization
applications listed in the Provisional Patent Application Number and Respiratory Diseases (NCIRD), at the
Supplementary Information section of 60/682,495, filed 05/19/2005, entitled Centers for Disease Control and
this notice. ‘‘Functional Epitopes of Streptococcus Prevention (CDC), describe methods to
DATES: Only written comments and/or Pneumonia PSAA Antigen and Uses bolster the human body’s own
applications for a license which are Thereof’’ (HHS Reference No. E–338– mechanisms to fight infection by
sradovich on DSK3GMQ082PROD with NOTICES

received by the Technology Transfer 2013/0–US–01); PCT Patent Application enhancing an innate immune response,
and Intellectual Property Office, Number PCT/US2005/027290, filed opsonophagocytosis. The specific 24
National Institute of Allergy and 07/29/2005, entitled ‘‘Functional amino acid peptide sequence (P4) acts
Infectious Diseases on or before July 2, Epitopes of Streptococcus Pneumonia as a polymorphonuclear cell activator.
2018 will be considered. PSAA Antigen and Uses Thereof’’ (HHS P4 can be administered in vivo along
ADDRESSES: Requests for copies of the Reference No. E–338–2013/0–PCT–02); with disease-specific antibodies to
patent applications, inquiries, and Australia Patent Number 2005332058, enhance systemic bacterial clearance,

VerDate Sep<11>2014 17:11 Jun 14, 2018 Jkt 244001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\15JNN1.SGM 15JNN1

Document Created: 2018-11-02 12:00:42
Document Modified: 2018-11-02 12:00:42

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 27-28, 2018.
FR Citation		83 FR 28001

83 FR 28001 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 116 (June 15, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health